Shionogi Lays Out R&D Goals Ahead of Crestor Challenges
This article was originally published in Scrip
Executive Summary
Japan's Shionogi is looking to bolster its presence in core therapeutic areas, unveiling positive new data for a novel constipation therapy and a raft of anti-infective projects at a recent R&D update.